GB0505541D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0505541D0
GB0505541D0 GBGB0505541.3A GB0505541A GB0505541D0 GB 0505541 D0 GB0505541 D0 GB 0505541D0 GB 0505541 A GB0505541 A GB 0505541A GB 0505541 D0 GB0505541 D0 GB 0505541D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0505541.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0505541.3A priority Critical patent/GB0505541D0/en
Publication of GB0505541D0 publication Critical patent/GB0505541D0/en
Priority to RU2007138263/15A priority patent/RU2007138263A/ru
Priority to AU2006224796A priority patent/AU2006224796A1/en
Priority to BRPI0607795-1A priority patent/BRPI0607795A2/pt
Priority to JP2008501223A priority patent/JP2008533079A/ja
Priority to US11/908,895 priority patent/US20090227620A1/en
Priority to CA002599470A priority patent/CA2599470A1/en
Priority to KR1020077021073A priority patent/KR20070113226A/ko
Priority to CNA2006800080245A priority patent/CN101137375A/zh
Priority to EP06707567A priority patent/EP1861098A1/en
Priority to PCT/EP2006/002382 priority patent/WO2006097292A1/en
Priority to MX2007011320A priority patent/MX2007011320A/es
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0505541.3A 2005-03-17 2005-03-17 Organic compounds Ceased GB0505541D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB0505541.3A GB0505541D0 (en) 2005-03-17 2005-03-17 Organic compounds
MX2007011320A MX2007011320A (es) 2005-03-17 2006-03-15 Compuestos antiinflamatorios.
JP2008501223A JP2008533079A (ja) 2005-03-17 2006-03-15 抗炎症化合物
AU2006224796A AU2006224796A1 (en) 2005-03-17 2006-03-15 Anti-inflammatory compounds
BRPI0607795-1A BRPI0607795A2 (pt) 2005-03-17 2006-03-15 compostos antiinflamatórios
RU2007138263/15A RU2007138263A (ru) 2005-03-17 2006-03-15 Противовоспалительные соединения
US11/908,895 US20090227620A1 (en) 2005-03-17 2006-03-15 Anti-inflammatory compounds
CA002599470A CA2599470A1 (en) 2005-03-17 2006-03-15 Anti-inflammatory compounds
KR1020077021073A KR20070113226A (ko) 2005-03-17 2006-03-15 소염 화합물
CNA2006800080245A CN101137375A (zh) 2005-03-17 2006-03-15 抗炎化合物
EP06707567A EP1861098A1 (en) 2005-03-17 2006-03-15 Anti-inflammatory compounds
PCT/EP2006/002382 WO2006097292A1 (en) 2005-03-17 2006-03-15 Anti-inflammatory compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0505541.3A GB0505541D0 (en) 2005-03-17 2005-03-17 Organic compounds

Publications (1)

Publication Number Publication Date
GB0505541D0 true GB0505541D0 (en) 2005-04-27

Family

ID=34531452

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0505541.3A Ceased GB0505541D0 (en) 2005-03-17 2005-03-17 Organic compounds

Country Status (12)

Country Link
US (1) US20090227620A1 (enExample)
EP (1) EP1861098A1 (enExample)
JP (1) JP2008533079A (enExample)
KR (1) KR20070113226A (enExample)
CN (1) CN101137375A (enExample)
AU (1) AU2006224796A1 (enExample)
BR (1) BRPI0607795A2 (enExample)
CA (1) CA2599470A1 (enExample)
GB (1) GB0505541D0 (enExample)
MX (1) MX2007011320A (enExample)
RU (1) RU2007138263A (enExample)
WO (1) WO2006097292A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200900960A1 (ru) * 2007-01-31 2010-02-26 Новартис Аг Производные пиперидинацетамида для лечения воспалительных или аллергических заболеваний
CA2698814A1 (en) 2007-09-17 2009-03-26 Preglem S.A. Treatment of oestrogen dependant conditions in pre-menopausal women
TW200936136A (en) * 2008-01-28 2009-09-01 Sanofi Aventis Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application
ES2555260T3 (es) 2010-06-15 2015-12-30 Bayer Intellectual Property Gmbh Derivados de diamida de ácido antranílico
CN102657642B (zh) * 2012-04-24 2014-01-15 广东省农业科学院兽医研究所 Irosustat在制备抗柔嫩艾美耳球虫药物中的应用
CA2874621A1 (en) 2012-05-22 2013-11-28 Genentech, Inc. N-substituted benzamides and their use in the treatment of pain
CN107417601A (zh) * 2017-04-06 2017-12-01 成都弥贝生物科技有限公司 具有抗菌活性的取代2‑酰胺磺酰基‑4,6‑芳基吡啶
KR102458689B1 (ko) * 2020-07-08 2022-10-25 원광대학교산학협력단 피페리딘 화합물 및 이의 제조 방법
WO2025079965A1 (ko) * 2023-10-10 2025-04-17 주식회사 넥시온바이오텍 치주 질환의 예방 또는 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807779D0 (en) * 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
US6986938B2 (en) * 2001-10-03 2006-01-17 A & A Manufacturing Co., Inc. Bellows with molded panels
AR037097A1 (es) * 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
AR039156A1 (es) * 2002-03-28 2005-02-09 Novartis Ag Amidas del acido piperidinilamino sulfamico o piperazinil sulfamico y su uso para la manufactura de un medicamento en enfermedades mediadas por la accion de la sulfatasa esteroide
AR041952A1 (es) * 2002-11-14 2005-06-01 Novartis Ag N-sulfonilaminotiazol

Also Published As

Publication number Publication date
BRPI0607795A2 (pt) 2009-06-13
MX2007011320A (es) 2007-11-08
US20090227620A1 (en) 2009-09-10
AU2006224796A1 (en) 2006-09-21
JP2008533079A (ja) 2008-08-21
CN101137375A (zh) 2008-03-05
KR20070113226A (ko) 2007-11-28
WO2006097292A1 (en) 2006-09-21
EP1861098A1 (en) 2007-12-05
RU2007138263A (ru) 2009-04-27
CA2599470A1 (en) 2006-09-21

Similar Documents

Publication Publication Date Title
GB0510390D0 (en) Organic compounds
GB0526246D0 (en) Organic compounds
GB0507575D0 (en) Organic compounds
GB0500435D0 (en) Organic compounds
GB0507696D0 (en) Organic compounds
GB0500785D0 (en) Organic compounds
GB0505969D0 (en) Organic compounds
GB0508319D0 (en) Organic compounds
GB0502358D0 (en) Organic compounds
GB0505219D0 (en) Organic compounds
GB0503646D0 (en) Organic compounds
GB0504850D0 (en) Organic compounds
GB0507298D0 (en) Organic compounds
GB0511060D0 (en) Organic compounds
GB0510810D0 (en) Organic compounds
GB0504544D0 (en) Organic compounds
GB0508992D0 (en) Organic compounds
GB0501237D0 (en) Organic compounds
GB0511066D0 (en) Organic compounds
GB0500784D0 (en) Organic compounds
GB0504203D0 (en) Organic compounds
GB0511686D0 (en) Organic compounds
GB0500020D0 (en) Organic compounds
GB0507695D0 (en) Organic compounds
GB0511063D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)